AGUIRRE FERNANDO 4

What Happened

• Fernando Aguirre, a director of CVS Health Corp (CVS), was awarded 1,563 shares on May 14, 2026. The shares were issued at $97.15 per share, for a total value of roughly $151,845. The transaction is reported as an acquisition (award/grant), not an open-market purchase.

Key Details

• Transaction date: 2026-05-14; Filing date (Form 4): 2026-05-15 (timely, filed the next business day).
• Transaction type/code: A — Award/Grant; 1,563 shares acquired at $97.15/share.
• Reported total value: approximately $151,845 (1,563 × $97.15).
• Shares owned after transaction: not specified in the provided excerpt of the filing — see the full Form 4 for post-transaction holdings.
• Footnote: F1 — shares consist of common stock issued in payment of a semi‑annual director retainer at market price under the 2017 Incentive Compensation Plan.
• No 10b5-1 plan, tax-withholding sale, or derivative exercise was indicated in the provided details.

Context

• This was a routine director compensation event (retainer paid in stock), not a market buy or sale. Such awards are common for board service and do not necessarily signal the director’s view on the company’s short-term stock direction. For complete holdings and additional context, retail investors should review the full Form 4 (accession 0000064803-26-000076).